Khasnis A, Gokula RM. Spider nevus. J Postgrad Med. 2002 Oct-Dec. 48(4):307-9. [QxMD MEDLINE Link]. [Full Text].
Finn SM, Rowland M, Lawlor F, Kinsella W, Chan L, Byrne O, et al. The significance of cutaneous spider naevi in children. Arch Dis Child. 2006 Jul. 91(7):604-5. [QxMD MEDLINE Link]. [Full Text].
Ali MA. Spider nevi secondary to alcoholic chronic liver disease. Cleve Clin J Med. 2022 Jun 1. 89 (6):301-302. [QxMD MEDLINE Link]. [Full Text].
Connor SG, Parizel PM, Wycoco V, Prentice DA. The relationship between spider naevi & de novo arteriovenous malformations in chronic liver disease. BJR Case Rep. 2022 Sep 12. 8 (5):20220081. [QxMD MEDLINE Link]. [Full Text].
Requena L, Sangueza OP. Cutaneous vascular anomalies. Part I. Hamartomas, malformations, and dilation of preexisting vessels. J Am Acad Dermatol. 1997 Oct. 37(4):523-49; quiz 549-52. [QxMD MEDLINE Link]. [Full Text].
Henry F, Quatresooz P, Valverde-Lopez JC, Piérard GE. Blood vessel changes during pregnancy: a review. Am J Clin Dermatol. 2006. 7(1):65-9. [QxMD MEDLINE Link]. [Full Text].
Graham-Brown RA. Hepatobiliary System and the Skin. Irwin Freedberg AE, Klaus Wolff, K Frank Austen, Lowell Goldsmith, Stephen Katz, Thomas Fitzpatric. Fitzpatrick's Dermatology In General Medicine. Fifth. New York: McGraw-Hill; 1999. 1918.
Salem A, Gamil H, Hamed M, Galal S. Nail changes in patients with liver disease. J Eur Acad Dermatol Venereol. 2010 Jun. 24(6):649-54. [QxMD MEDLINE Link]. [Full Text].
Li H, Wang R, Méndez-Sánchez N, et al. Impact of spider nevus and subcutaneous collateral vessel of chest/abdominal wall on outcomes of liver cirrhosis. Arch Med Sci. 2019 Mar. 15 (2):434-448. [QxMD MEDLINE Link]. [Full Text].
Chuh A, Zawar V, Sciallis G. Does dermatoscopy facilitate the detection and diagnosis of vascular skin lesions? A case-control study. J R Coll Physicians Edinb. 2018 Sep. 48 (3):210-216. [QxMD MEDLINE Link].
Detry O, De Roover A. Images in clinical medicine. Spider angiomas. N Engl J Med. 2009 Jan 15. 360(3):280. [QxMD MEDLINE Link]. [Full Text].
Collyer J, Boone SL, White LE, Rademaker A, West DP, Anderson K. Comparison of treatment of cherry angiomata with pulsed-dye laser, potassium titanyl phosphate laser, and electrodesiccation: a randomized controlled trial. Arch Dermatol. 2010 Jan. 146(1):33-7. [QxMD MEDLINE Link]. [Full Text].
Sivarajan V, Al Aissami M, Maclaren W, Mackay IR. Recurrence of spider naevi following treatment with 585 nm pulsed dye laser. J Plast Reconstr Aesthet Surg. 2007. 60(6):668-71. [QxMD MEDLINE Link]. [Full Text].
Becher GL, Cameron H, Moseley H. Treatment of superficial vascular lesions with the KTP 532-nm laser: experience with 647 patients. Lasers Med Sci. 2014 Jan. 29 (1):267-71. [QxMD MEDLINE Link]. [Full Text].
Bjerring P, Christiansen K, Troilius A. Intense pulsed light source for treatment of facial telangiectasias. J Cosmet Laser Ther. 2001 Dec. 3(4):169-73. [QxMD MEDLINE Link]. [Full Text].
Kono T, Sakurai H, Groff WF, Chan HH, Takeuchi M, Yamaki T, et al. Comparison study of a traditional pulsed dye laser versus a long-pulsed dye laser in the treatment of early childhood hemangiomas. Lasers Surg Med. 2006 Feb. 38(2):112-5. [QxMD MEDLINE Link]. [Full Text].
Michel JL. Treatment of hemangiomas with 595 nm pulsed dye laser dermobeam. Eur J Dermatol. 2003 Mar-Apr. 13(2):136-41. [QxMD MEDLINE Link].
Tan E, Vinciullo C. Pulsed dye laser treatment of spider telangiectasia. Australas J Dermatol. 1997 Feb. 38(1):22-5. [QxMD MEDLINE Link]. [Full Text].
Tan OT, Gilchrest BA. Laser therapy for selected cutaneous vascular lesions in the pediatric population: a review. Pediatrics. 1988 Oct. 82(4):652-62. [QxMD MEDLINE Link]. [Full Text].
Woo SH, Ahn HH, Kim SN, Kye YC. Treatment of vascular skin lesions with the variable-pulse 595 nm pulsed dye laser. Dermatol Surg. 2006 Jan. 32(1):41-8. [QxMD MEDLINE Link]. [Full Text].
Yang J, An X, Li Y, Tao J. Multi-wavelength laser treatments of spider nevi. Lasers Med Sci. 2019 Jun. 34 (4):737-742. [QxMD MEDLINE Link].
Udell JA, Wang CS, Tinmouth J, et al. Does this patient with liver disease have cirrhosis?. JAMA. 2012 Feb. 307(8):832-42. [QxMD MEDLINE Link]. [Full Text].
Niederau C, Lange S, Frühauf M, Thiel A. Cutaneous signs of liver disease: value for prognosis of severe fibrosis and cirrhosis. Liver Int. 2008 May. 28(5):659-66. [QxMD MEDLINE Link]. [Full Text].
Hane H, Yokota K, Kono M, Muro Y, Akiyama M. Extraordinarily large, giant spider angioma in an alcoholic cirrhotic patient. Int J Dermatol. 2014 Feb. 53(2):e119-21. [QxMD MEDLINE Link].
Yalcin K, Ekin N, Atay A. Unusual presentations of spider angiomas. Liver Int. 2013 Mar. 33(3):487. [QxMD MEDLINE Link].
Li CP, Lee FY, Hwang SJ, Chang FY, Lin HC, Lu RH, et al. Role of substance P in the pathogenesis of spider angiomas in patients with nonalcoholic liver cirrhosis. Am J Gastroenterol. 1999 Feb. 94(2):502-7. [QxMD MEDLINE Link]. [Full Text].
Isner JM, Pieczek A, Schainfeld R, Blair R, Haley L, Asahara T, et al. Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb. Lancet. 1996 Aug 10. 348(9024):370-4. [QxMD MEDLINE Link]. [Full Text].
Li CP, Lee FY, Hwang SJ, Lu RH, Lee WP, Chao Y, et al. Spider angiomas in patients with liver cirrhosis: role of vascular endothelial growth factor and basic fibroblast growth factor. World J Gastroenterol. 2003 Dec. 9(12):2832-5. [QxMD MEDLINE Link]. [Full Text].
Li CP, Lee FY, Hwang SJ, Chang FY, Lin HC, Lu RH, et al. Spider angiomas in patients with liver cirrhosis: role of alcoholism and impaired liver function. Scand J Gastroenterol. 1999 May. 34(5):520-3. [QxMD MEDLINE Link]. [Full Text].
Iino S. [Differentiation alcoholic liver cirrhosis from viral liver cirrhosis]. Nippon Rinsho. 1994 Jan. 52(1):174-80. [QxMD MEDLINE Link].